(Q53471048)

14 May 2018

title

Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide. (English)

1 reference

14 May 2018

author name string

M L Salgaller

1

1 reference

14 May 2018

J S Weber

2

1 reference

14 May 2018

S Koenig

3

1 reference

14 May 2018

J R Yannelli

4

1 reference

14 May 2018

S A Rosenberg

5

1 reference

14 May 2018

publication date

1 August 1994

1 reference

14 May 2018

Cancer Immunology, Immunotherapy

published in

1 reference

14 May 2018

volume

39

1 reference

14 May 2018

issue

2

1 reference

14 May 2018

page(s)

105-116

1 reference

14 May 2018

Role of the major histocompatibility complex class I antigens in tumor growth and metastasis

cites work

1 reference

12 December 2020

A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability

1 reference

12 December 2020

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E

1 reference

12 December 2020

Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide

1 reference

12 December 2020

Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy

1 reference

12 December 2020

1 reference

12 December 2020

Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory.

1 reference

12 December 2020

Toward a genetic analysis of tumor rejection antigens.

1 reference

12 December 2020

Perspectives on the role of MHC antigens in normal and malignant cell development

1 reference

12 December 2020

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

12 December 2020

Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ

1 reference

12 December 2020

The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens

1 reference

12 December 2020

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

1 reference

12 December 2020

Identification of human cancers deficient in antigen processing

1 reference

12 December 2020

CD4+ T cell clones specific for the human p97 melanoma-associated antigen can eradicate pulmonary metastases from a murine tumor expressing the p97 antigen

1 reference

12 December 2020

Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes

1 reference

12 December 2020

Identification of two cytotoxic T lymphocyte-recognized epitopes in the Ras protein

1 reference

12 December 2020

Presentation of soluble antigen to human T cells by products of multiple HLA-linked loci: analysis of antigen presentation by a panel of cloned, autologous, HLA-mutant Epstein-Barr virus-transformed lymphoblastoid cell lines

1 reference

12 December 2020

Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host

1 reference

12 December 2020

Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials

1 reference

12 December 2020

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

12 December 2020

Role of IL-6, IL-2, and IL-4 in the in vitro induction of cytotoxic T cells

1 reference

12 December 2020

Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.

1 reference

12 December 2020

Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas.

1 reference

12 December 2020

Antigen presentation by human B cells: T cell proliferation induced by Epstein Barr virus B lymphoblastoid cells

1 reference

12 December 2020

Adoptive immunotherapy with peripheral blood lymphocytes cocultured in vitro with autologous tumor cells and interleukin-2.

1 reference

12 December 2020

Naturally processed peptides

1 reference

12 December 2020

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

12 December 2020

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

12 December 2020

Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide

1 reference

12 December 2020

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

1 reference

12 December 2020

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

12 December 2020

Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients

1 reference

12 December 2020

Differential expression of MAGE-1, -2, and -3 messenger RNA in transformed and normal human cell lines.

1 reference

12 December 2020

Unique tumor-specific antigens

1 reference

12 December 2020

Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells

1 reference

12 December 2020

Specific release of cytokines by lymphocytes infiltrating human melanomas in response to shared melanoma antigens.

1 reference

12 December 2020

Structure of the gene of tum- transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells

1 reference

12 December 2020

The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice

1 reference

12 December 2020

Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes

1 reference

12 December 2020

Antigen presentation by B cells and its significance in T-B interactions

1 reference

12 December 2020

Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide

1 reference

12 December 2020

Presentation of three different viral peptides, HTLV-1 Tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule.

1 reference

12 December 2020

Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors

1 reference

12 December 2020

Antigen recognition by class I-restricted T lymphocytes

1 reference

12 December 2020

Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and IFN-gamma by human tumor-infiltrating lymphocytes after autologous tumor stimulation

1 reference

12 December 2020

Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells

1 reference

12 December 2020

Tumor-specific cytolysis by lymphocytes infiltrating human melanomas

1 reference

12 December 2020

Clonal analysis of the cytolytic T-cell response to human tumors

1 reference

12 December 2020

Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation

1 reference

12 December 2020

A mutant p53 tumor suppressor protein is a target for peptide-induced CD8+ cytotoxic T-cells

1 reference

12 December 2020

Identifiers

DOI

10.1007/S002620050101

1 reference

14 May 2018

1 reference

14 May 2018